Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/ddg.14304 | DOI Listing |
Clin Genet
September 2024
CEREMAIA, Department of Genetics, CHU of Montpellier, INSERM, University of Montpellier, Montpellier, France.
Mod Rheumatol
July 2023
Department of paediatrics, Mansoura University Faculty of Medicine, Mansoura, Egypt.
Objective: To explore early features that can predict colchicine resistance in familial Mediterranean fever (FMF) patients.
Methods: It included FMF cases who fulfilled the Yalcinkaya-Ozen criterion and were on colchicine for at least 6 months. Data were collected from medical files and interpreted with respect to clinical parameters, incluing the auto-inflammatory diseases activity index (AIDAI) and FMF severity score.
Front Pediatr
January 2022
Department of Rheumatology, Umraniye Research and Training Hospital, University of Health Sciences, Istanbul, Turkey.
Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease manifesting phenotypic heterogeneity. It is a clinically diagnosed disease supported by gene mutation analysis. However, the phenotype-genotype correlation is not yet established clearly.
View Article and Find Full Text PDFScand J Rheumatol
January 2022
Internal Medicine Department, Reference Centre for Autoinflammatory Diseases and Amyloidosis (CEREMAIA), Tenon Hospital, Paris, France.
: Familial Mediterranean fever (FMF) is the most frequent monogenic autoinflammatory disease. It is associated with mutations. Its main features are recurrent episodes of fever and serositis.
View Article and Find Full Text PDFJ Dtsch Dermatol Ges
April 2021
Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum des Saarlandes, Homburg/Saar.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!